A tale of two stakeholder groups in regulating healthcare AI
Despite significant spending on healthcare in the US, the industry is slow to adopt AI technology that can cut costs and improve efficiency. In this CPI...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
CRA experts provide consultation and expert testimony in healthcare matters related to attempted monopolization or collusion and price fixing. Our experts use cutting-edge theory and empirical analyses to distinguish aggressive competition that is procompetitive from business practices that hinder competition or to assess the plausibility of collusion claims and to perform statistical analyses to distinguish between competitive and anti-competitive pricing and payment.
Despite significant spending on healthcare in the US, the industry is slow to adopt AI technology that can cut costs and improve efficiency. In this CPI...
Previously in a series of policy letters, Federal Trade Commission staff expressed concerns that transparency could lead to coordinated behavior and higher...